Illinois HB3759 prohibits contracts that delay drug entry into the marketplace.
HB3759 amends the Illinois Food, Drug and Cosmetic Act to prohibit contracts that delay the entry of a drug into the marketplace. This change adds a new section, 3.21a, to the Act, which explicitly forbids such contracts. The bill aims to ensure timely access to drugs for consumers in Illinois.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.